We are live on ! Find out more
NMTR

9 Meters Biopharma
NMTR

Delisted

NMTR was delisted on the 25th of July, 2023.

Back to rankings

1 hedge funds and large institutions have $0 invested in 9 Meters Biopharma in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% less funds holding

Funds holding: 6 → 1 (-5)

100% less capital invested

Capital invested by funds: $22.7K → $0 (-$22.7K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 5

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-5
Holders Change %
-83.33%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$20.1K
2
RCM
Requisite Capital Management
Texas
-$180
3
BCMLT
Beacon Capital Management LLC (Tennessee)
Tennessee
-$104
4
SPIA
Steward Partners Investment Advisory
New York
-$13
5
RFA
Register Financial Advisors
Georgia
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
– -$20.1K -1,672,627 Closed
RCM
2
Requisite Capital Management
Texas
– -$180 -15,000 Closed
SPIA
3
Steward Partners Investment Advisory
New York
– -$13 -1,117 Closed
BCMLT
4
Beacon Capital Management LLC (Tennessee)
Tennessee
– -$104 -155 Closed
RFA
5
Register Financial Advisors
Georgia
– -$1 -100 Closed

NMTR Hedge Fund Activity: Q4 2023 in Review

1 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q4 2023, worth a combined $0 — down 100% from $22.7K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of NMTR and 0 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Sabby Management, exiting entirely with an estimated $20.1K sold.

  • 1 institutional investor held 9 Meters Biopharma (NMTR) as of Q4 2023, down from 6 in Q3 2023.
  • Funds reported $0 of 9 Meters Biopharma stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new 9 Meters Biopharma positions in Q4 2023 and 5 closed out, a net change of -5 holders.
  • The largest 9 Meters Biopharma seller in Q4 2023 was Sabby Management, an estimated $20.1K sold.

Based on aggregated 13F filings for Q4 2023.